Venue: Hall No. 2 ( A) NSE Complex, Goregaon, Mumbai
Date: February 13th, 2009
Registration, Coffee & Tea (9.00 Am - 9.30 AM)
Inaugural Session (9.30 AM. - 10.30 AM)
Leveraging the opportunity in Pharmaceuticals
|
Welcome Address |
Mr. Jasu Shah
Chairman, CHEMTECH Foundation |
|
Address by |
Mr. Ranjit Shahani
Chairman. Novartis India Ltd |
Keynote Address Globalization
Leveraging the opportunity
in pharmaceuticals
|
Mr. Ranga Iyer
Managing Director,
Wyeth Ltd
|
|
Concluding Remarks |
Mr. Tapan Ray
Director General, OPPI
|
|
10.30 - 10.45 |
Q & A |
Session - I (10.45 AM - 13.00 PM):
Innovation
Chairman: Mr. Tapan Ray, Director General, OPPI
Innovation as a Strategy for sustainable growth
(10.45 - 11.15) |
Dr. Praful Naik
Chief Scientific Officer & Executive Director, Bilcare Ltd |
Innovative Model for Rural
Healthcare Access.
(11.15 - 11.45) |
Mr. Anuj Pasrija
Country Head Arogya,
Novartis India Ltd. |
Changing Paradigm in Pharmaceutical R&D
(11.45 - 12.15)
|
Dr. Ajit Dangi
President & CEO, Danssen Consulting
|
Drug Discovery - Busting the block Buster Model
(12.15 - 12.45)
|
Dr Ramani Aiyar
Chief Scientific Officer,
Actis Biologics P. Ltd
|
|
12.45 - 13.00
|
Q & A |
LUNCH - 13.00 PM - 14.00 PM
Session - II (14.00 PM - 16.20PM)
Challenges & Prospects
Chairman: Mr. Daara Patel, Secretary General, IDMA
Managing Intellectual
Property as a competitive
Strategy (14.00-14.30)
|
Dr. Prabuddha Ganguli
CEO, Vision - IPR
|
Regulatory pathways
for Biosimilars -
Way forward
(14.30 - 15.00) |
Dr. Dhananjay Bakhle
Sr. V.P Reliance Life Science
|
Advances in stem cell
research (15.00-15.30) |
Dr Goutam Pujari,
Head-Clinical Research,
Reliance Life Sciences
|
Tea / Coffee (15.30 - 15.45 PM)
Pharmaceutical Outsourcing Opportunities in India
(15.45-16.15)
|
Mr.Subodh Priolkar, General Manager, Colorcon - South Asia.
|
Engineering Solutions for Regulatory Compliances & Validation
(16.15 - 16.45)
|
Mr. Kevin Gribbin, Executive Manager, Intergraph
|
The Role of Pharmaceutical
SMEs in Global Economy
(16.45-17.15)
|
Mr Smitesh Shah
CMD Calyx Chemicals & Pharmaceuticals Ltd.
|
|
17.15 - 17.30
|
Q & A
|
*Confirmation awaited
|
